Home / Resource Library / Frontline Sobuzoxane Plus Etoposide and Rituximab is Safe and Effective in Older DLBCL PopulationFrontline Sobuzoxane Plus Etoposide and Rituximab is Safe and Effective in Older DLBCL Population ESMO 2023